Index Entries

1975 Results
TitleIS Publication Date
NEURO-COVAX: An Italian Population-Based Study of Neurological Complications after COVID-19 VaccinationsOctober 21, 2023
Neuro-Ophthalmologic Symptoms Associated With the Moderna mRNA COVID-19 Vaccine: A Case ReportAugust 29, 2022
Neurologic Sequela of COVID-19: Guillain-Barré Syndrome Following Johnson & Johnson COVID-19 VaccinationApril 18, 2022
Neurological Adverse Reactions to SARS-CoV-2 VaccinesMay 30, 2023
Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case seriesJanuary 11, 2022
Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infectionOctober 25, 2021
Neurological Complications Following COVID-19 VaccinationNovember 29, 2022
Neurological Conditions Following COVID-19 Vaccinations: Chance or Association?February 04, 2022
Neurological side effects of SARS-CoV-2 vaccination are common and can be severeDecember 11, 2024
Neurological Side Effects of SARS-CoV-2 Vaccinations are Not Uncommon but Frequently IgnoredJune 27, 2022
Neuromuscular diseases associated with COVID-19 vaccines: a systematic review and pooled analysis of 258 patientsDecember 11, 2023
Neuropathic symptoms with SARS-CoV-2 vaccinationMay 17, 2022
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysisNovember 15, 2021
New COVID Select Memo Details Allegations of Wrongdoing and Illegal Activity by Dr. Fauci’s Senior Scientific AdvisorMay 22, 2024
New COVID Vaccine Numbers CHANGE EVERYTHING!May 24, 2024
New COVID-19 Treatments Add-On Payment (NCTAP)Last modified December 13, 2022
New Data Exposes the Corruption behind the Covid ResponseNovember 14, 2024
New report on UK excess deathsJanuary 2023
New VAERS analysis reveals hundreds of serious adverse events that the CDC and FDA never told us aboutNovember 9, 2021
New-Onset and Relapsed Membranous Nephropathy post SARS-CoV-2 and COVID-19 VaccinationSeptember 28, 2022
New-onset autoimmune phenomena post-COVID-19 vaccinationDecember 27, 2021
New-onset of rheumatic diseases following COVID-19 vaccination: the report of three cases and a literature reviewApril 16, 2024
New-onset psychosis following COVID-19 vaccination: a systematic reviewApril 12, 2024
New-onset psychosis following COVID-19 vaccination: a systematic reviewApril 12, 2024
New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic ReviewOctober 8, 2023
News release: FDA Approves First COVID-19 VaccineAugust 23, 2021
News release: FDA Approves First Treatment for COVID-19October 22, 2020
News release: FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 VaccineDecember 18, 2020
NHS key statistics: EnglandNovember 15, 2023
NHS waiting lists: Backlog hits record high with nearly six million awaiting treatment in EnglandOctober 14, 2021
NIH Documents Provide New Evidence U.S. Funded Gain-of-Function Research in WuhanSeptember 9, 2021
NIH email communications acquired by CHD via FOIA Request — Release #11
NIH in Early 2022 Abruptly Stopped Responding to People Injured by COVID ShotsFebruary 13, 2024
Ninety-third SAGE meeting on COVID-19July 7, 2021
Ninth Amendment to Declaration Under the Public Readiness and Emergency Preparedness (PREP} Act for Medical Countermeasures Against COVID-19September 14, 2021
No difference in risk of hospitalisation between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in NorwayDecember 10, 2021
No evidence for TGA's mRNA safety claimDecember 11, 2024
No learning loss in Sweden during the pandemic: Evidence from primary school reading assessmentsJune 2, 2022
No Nanobots in Vaccines — Just Lipids on the LooseSeptember 10, 2024
Nobel Laureate Luc Montagnier - Warns Covid Vaccine May Lead to 'Neurodegenerative Illness'May 27, 2021
Non-COVID Excess Deaths, 2020-21: Collateral Damage of Policy Choices?June 2022
Non-COVID-19 excess deaths by age and gender in the United States during the first three months of the COVID-19 pandemicOctober 10, 2020
Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza2019
Nonclinical Evaluation Report: BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY)January 8, 2021
Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Personal Protective and Environmental MeasuresMay 2020
Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021September 23, 2021
NSW COVID-19 Weekly Data Overview: Epidemiological weeks 51 and 52, ending 31 December 2022December 31, 2022
Observational Study on 255 Mechanically Ventilated Covid Patients at the Beginning of the USA PandemicMay 31, 2021
Occurrence of erythema multiforme following COVID-19 vaccination: a reviewApril 30, 2023
Ocular Complications Following Vaccination for COVID-19: A One-Year RetrospectiveFebruary 21, 2022